Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement.
Read Appendix 3B.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell